| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
|
Lancet
|
2006
|
7.33
|
|
2
|
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.
|
Nat Genet
|
2008
|
3.94
|
|
3
|
Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.
|
Eur J Nucl Med Mol Imaging
|
2003
|
2.77
|
|
4
|
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain.
|
Hum Gene Ther
|
2007
|
2.64
|
|
5
|
Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
|
J Clin Oncol
|
2006
|
2.41
|
|
6
|
Positron emission tomography in mantle cell lymphoma.
|
Leuk Lymphoma
|
2008
|
2.12
|
|
7
|
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
|
Proc Natl Acad Sci U S A
|
2007
|
1.73
|
|
8
|
Synthesis and biologic evaluation of (11)c-methyl-d-glucoside, a tracer of the sodium-dependent glucose transporters.
|
J Nucl Med
|
2003
|
1.51
|
|
9
|
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation.
|
Blood
|
2003
|
1.40
|
|
10
|
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
|
Arthritis Rheum
|
2006
|
1.37
|
|
11
|
[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?
|
Eur J Nucl Med Mol Imaging
|
2003
|
1.35
|
|
12
|
Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings.
|
Clin Nucl Med
|
2002
|
1.35
|
|
13
|
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
|
Eur J Nucl Med Mol Imaging
|
2004
|
1.30
|
|
14
|
A dual-targeting anticancer approach: soil and seed principle.
|
Radiology
|
2011
|
1.21
|
|
15
|
Molecular imaging of cell death.
|
Methods
|
2009
|
1.17
|
|
16
|
Reducing loss of image quality because of the attenuation artifact in uncorrected PET whole-body images.
|
J Nucl Med
|
2002
|
1.17
|
|
17
|
Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
|
J Nucl Med
|
2003
|
1.14
|
|
18
|
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
|
Neuroimage
|
2007
|
1.12
|
|
19
|
Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.
|
Mol Ther
|
2006
|
1.11
|
|
20
|
Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
|
J Nucl Med
|
2006
|
1.10
|
|
21
|
(18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.
|
J Nucl Med
|
2009
|
1.09
|
|
22
|
(18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis.
|
Eur J Nucl Med Mol Imaging
|
2010
|
1.08
|
|
23
|
Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.
|
Eur Heart J
|
2007
|
1.07
|
|
24
|
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2010
|
1.03
|
|
25
|
Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography.
|
Anticancer Res
|
2006
|
1.03
|
|
26
|
First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.03
|
|
27
|
Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
|
Bioconjug Chem
|
2007
|
1.01
|
|
28
|
Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.
|
Arch Gen Psychiatry
|
2009
|
1.01
|
|
29
|
Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone.
|
Epilepsia
|
2006
|
1.00
|
|
30
|
Noninvasive and quantitative monitoring of adult neuronal stem cell migration in mouse brain using bioluminescence imaging.
|
Stem Cells
|
2008
|
0.99
|
|
31
|
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.99
|
|
32
|
Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
|
J Clin Endocrinol Metab
|
2002
|
0.98
|
|
33
|
131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.96
|
|
34
|
Evolution of regional performance after an acute anterior myocardial infarction in humans using magnetic resonance tagging.
|
J Physiol
|
2003
|
0.95
|
|
35
|
An uncommon cause of headache after headbanging at a party.
|
Eur J Emerg Med
|
2009
|
0.95
|
|
36
|
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.94
|
|
37
|
Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
|
Nucl Med Biol
|
2010
|
0.94
|
|
38
|
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.93
|
|
39
|
FDG-PET: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.92
|
|
40
|
67Ga scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.92
|
|
41
|
Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
|
J Nucl Med
|
2006
|
0.91
|
|
42
|
Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo.
|
Bioorg Med Chem
|
2010
|
0.91
|
|
43
|
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.
|
Leuk Lymphoma
|
2007
|
0.90
|
|
44
|
Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium.
|
Circ Res
|
2007
|
0.89
|
|
45
|
The value of (18)FDG-PET for the detection of infected hip prosthesis.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.89
|
|
46
|
Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin.
|
Eur J Intern Med
|
2004
|
0.89
|
|
47
|
Molecular imaging of therapy response with (18)F-FLT and (18)F-FDG following cyclophosphamide and mTOR inhibition.
|
Am J Nucl Med Mol Imaging
|
2011
|
0.89
|
|
48
|
Evaluation of androgen-induced effects on the uptake of [18F]FDG, [11C]choline and [11C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model.
|
EJNMMI Res
|
2013
|
0.88
|
|
49
|
Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.87
|
|
50
|
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.87
|
|
51
|
Synthesis and evaluation of a (99m)Tc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECT.
|
Nucl Med Biol
|
2007
|
0.87
|
|
52
|
Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography.
|
Bioconjug Chem
|
2008
|
0.86
|
|
53
|
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.86
|
|
54
|
Fetal gene transfer with lentiviral vectors: long-term in vivo follow-up evaluation in a rat model.
|
Am J Obstet Gynecol
|
2007
|
0.85
|
|
55
|
Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression.
|
Neurobiol Aging
|
2006
|
0.85
|
|
56
|
Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.
|
Am Heart J
|
2006
|
0.84
|
|
57
|
Breast scintigraphy: procedure guidelines for tumour imaging.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.83
|
|
58
|
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.82
|
|
59
|
Positron emission tomography can reveal abdominal periaortitis.
|
Clin Nucl Med
|
2002
|
0.82
|
|
60
|
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.82
|
|
61
|
Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy.
|
J Nucl Med
|
2004
|
0.81
|
|
62
|
Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patients.
|
Surg Neurol
|
2006
|
0.80
|
|
63
|
Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy.
|
J Nucl Med
|
2007
|
0.80
|
|
64
|
Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.
|
MAGMA
|
2010
|
0.80
|
|
65
|
Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.
|
Bioorg Med Chem
|
2009
|
0.80
|
|
66
|
Synthesis of 18F-fluoroalkyl-beta-D-glucosides and their evaluation as tracers for sodium-dependent glucose transporters.
|
J Nucl Med
|
2003
|
0.79
|
|
67
|
Significant impact of transient deterioration of renal function on dosimetry in PRRT.
|
Ann Nucl Med
|
2012
|
0.79
|
|
68
|
Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease.
|
J Med Chem
|
2009
|
0.79
|
|
69
|
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
|
Leuk Lymphoma
|
2007
|
0.79
|
|
70
|
Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.
|
J Nucl Med
|
2004
|
0.78
|
|
71
|
Ga-68 DOTATOC PET/CT changed the therapeutic course of a patient with the sudden onset of vision problems.
|
Clin Nucl Med
|
2009
|
0.78
|
|
72
|
Evaluation of (99m)Tc-labeled tropanes with alkyl substituents on the 3beta-phenyl ring as potential dopamine transporter tracers.
|
Nucl Med Biol
|
2006
|
0.78
|
|
73
|
Septic pulmonary embolisms and metastatic infections from methicillin-resistant Staphylococcus aureus endocarditis on FDG PET/CT.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.78
|
|
74
|
Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography.
|
Bioorg Med Chem
|
2010
|
0.78
|
|
75
|
Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
|
Nucl Med Biol
|
2012
|
0.78
|
|
76
|
Wandering spleen on a 68Ga-DOTATOC-PET/CT scan.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.78
|
|
77
|
Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.
|
J Med Chem
|
2007
|
0.78
|
|
78
|
A nonsurgical porcine model of left ventricular dysfunction. Validation of myocardial viability using dobutamine stress echocardiography and positron emission tomography.
|
Int J Cardiovasc Intervent
|
2000
|
0.77
|
|
79
|
Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging.
|
Mol Imaging Biol
|
2011
|
0.77
|
|
80
|
Biological evaluation of a technetium-99m-labeled integrated tropane-BAT and its piperidine congener as potential dopamine transporter imaging agents.
|
Nucl Med Biol
|
2006
|
0.77
|
|
81
|
Technetium-99m labelled integrated tropane-BAT as a potential dopamine transporter tracer.
|
Bioorg Med Chem
|
2005
|
0.77
|
|
82
|
In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist.
|
Biol Psychiatry
|
2008
|
0.77
|
|
83
|
Bioluminescence imaging of therapy response does not correlate with FDG-PET response in a mouse model of Burkitt lymphoma.
|
Am J Nucl Med Mol Imaging
|
2012
|
0.76
|
|
84
|
Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.76
|
|
85
|
PET versus PET-CT in patient with suspicion of non-Hodgkin lymphoma recurrence.
|
Clin Nucl Med
|
2007
|
0.76
|
|
86
|
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.
|
EJNMMI Res
|
2013
|
0.75
|
|
87
|
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
|
J Clin Oncol
|
2011
|
0.75
|
|
88
|
Development and biological evaluation of 99mTc-BAT-tropane esters.
|
Nucl Med Biol
|
2005
|
0.75
|
|
89
|
PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.
|
Eur J Nucl Med Mol Imaging
|
2001
|
0.75
|
|
90
|
Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction.
|
J Chromatogr A
|
2007
|
0.75
|
|
91
|
A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.
|
J Med Chem
|
2007
|
0.75
|
|
92
|
Bone scintigraphy in electrocution wounds and comparison with FDG-PET images.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.75
|
|
93
|
FDG-PET scan in the diagnosis of postmeningococcal pericarditis.
|
Clin Nucl Med
|
2002
|
0.75
|
|
94
|
Dynamic scintigraphy suggested renal malrotation in a patient with a kidney mass on ultrasound.
|
Clin Nucl Med
|
2007
|
0.75
|
|
95
|
Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.
|
Bioorg Med Chem Lett
|
2007
|
0.75
|
|
96
|
Synthesis and biological evaluation of a technetium-99m(I)-tricarbonyl-labelled phenyltropane derivative.
|
Bioorg Med Chem Lett
|
2005
|
0.75
|